References

• 2005US Valuation of the EQ-5D Health States1,281 cited
• 2000Preference-Based Measures in Economic Evaluation in Health Care295 cited
• 2007Health Utilities Using the EQ-5D in Studies of Cancer285 cited
• 2002A new explanation for the difference between time trade‐off utilities and standard gamble utilities236 cited
• 2002Utilities Measured by Rating Scale, Time Trade-off, and Standard Gamble: Review and Reference for Health Care Professionals.140 cited
• 2004Correcting Biases in Standard Gamble and Time Tradeoff Utilities126 cited
• 2003Cost–Benefit Analysis and Health Care Evaluations92 cited
• 2001Patient Preferences for Adjuvant Interferon Alfa-2b Treatment90 cited
• 1995Comparison of Time-tradeoff Utilities and Rating Scale Values of Cancer Patients and Their Relatives87 cited
• 2000Unstable Preferences:86 cited
• 2007Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen Alone or in Combination) trial74 cited
• 1998Prostate Cancer Patients' Utilities for Health States70 cited
• 2003A consistency test of the time trade-off64 cited
• 1994Developing and Testing a Multimedia Presentation of a Health-state Description